The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 04, 2020

Filed:

Nov. 13, 2018
Applicant:

Medivance Incorporated, Louisville, CO (US);

Inventors:

Gary A. Carson, Golden, CO (US);

Gary Gruszecki, Golden, CO (US);

Robert Proctor, Lakewood, CO (US);

Assignee:

Medivance Incorporated, Louisville, CO (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61F 7/00 (2006.01); A61B 34/00 (2016.01);
U.S. Cl.
CPC ...
A61F 7/0085 (2013.01); A61F 7/00 (2013.01); A61B 34/25 (2016.02); A61F 2007/0054 (2013.01); A61F 2007/0086 (2013.01); A61F 2007/0093 (2013.01); A61F 2007/0095 (2013.01); A61F 2007/0096 (2013.01);
Abstract

A patient temperature control system and method are provided for automated temperature control according to a programmed protocol. In one aspect, at least one programmed protocol may be established for each of a plurality of patient thermal therapy phases. In turn, the temperature of a thermal exchange medium may be controlled, based at least in part, upon the programmed protocol, during each of the phases. In another aspect, a plurality of programmed protocols may be established, wherein a selected one of the protocols (e.g. selected by a user at a user interface) may be utilized for automated temperature control during patient thermal therapy. The protocol(s) may include a target patient temperature and/or a set duration for one or more of the phase of thermal therapy. Further, the protocol(s) may be user-definable and modifiable during therapy. In a multi-phase configuration, automatic termination and initiation of successive phases may be selectively established by a user, based on target patient temperature data and/or set duration data on a phase-specific basis.


Find Patent Forward Citations

Loading…